Germline TP53 mutations is common in patients with two early‐onset primary malignancies. (8th October 2014) - Chak, B. P.; Chan, E. S.; Tong, J. H.; Leung, A. W.; Cheng, F. W.; Lam, G. K.; Shing, M. M.; Li, C. K.; To, K. F.